142 related articles for article (PubMed ID: 7519148)
1. Neuroprotective efficacy of N omega-nitro-L-arginine after focal cerebral ischemia in the mouse and inhibition of cortical nitric oxide synthase.
Carreau A; Duval D; Poignet H; Scatton B; Vigé X; Nowicki JP
Eur J Pharmacol; 1994 May; 256(3):241-9. PubMed ID: 7519148
[TBL] [Abstract][Full Text] [Related]
2. Failure to prevent selective CA1 neuronal death and reduce cortical infarction following cerebral ischemia with inhibition of nitric oxide synthase.
Buchan AM; Gertler SZ; Huang ZG; Li H; Chaundy KE; Xue D
Neuroscience; 1994 Jul; 61(1):1-11. PubMed ID: 7526264
[TBL] [Abstract][Full Text] [Related]
3. The effect of nitric oxide synthase inhibition on infarct volume after reversible focal cerebral ischemia in conscious rats.
Kuluz JW; Prado RJ; Dietrich WD; Schleien CL; Watson BD
Stroke; 1993 Dec; 24(12):2023-9. PubMed ID: 7504336
[TBL] [Abstract][Full Text] [Related]
4. Effects of central inhibition of nitric oxide synthase on focal cerebral ischemia in rats.
Hamada J; Greenberg JH; Croul S; Dawson TM; Reivich M
J Cereb Blood Flow Metab; 1995 Sep; 15(5):779-86. PubMed ID: 7545692
[TBL] [Abstract][Full Text] [Related]
5. Antagonism by NG-nitro-L-arginine of L-glutamate-induced neurotoxicity in cultured neonatal rat cortical neurons. Prolonged application enhances neuroprotective efficacy.
Vigé X; Carreau A; Scatton B; Nowicki JP
Neuroscience; 1993 Aug; 55(4):893-901. PubMed ID: 7694182
[TBL] [Abstract][Full Text] [Related]
6. Chronic administration of a nitric oxide synthase inhibitor, N omega-nitro-L-arginine, and drug-induced increase in cerebellar cyclic GMP in vivo.
Bansinath M; Arbabha B; Turndorf H; Garg UC
Neurochem Res; 1993 Oct; 18(10):1063-6. PubMed ID: 7504789
[TBL] [Abstract][Full Text] [Related]
7. Nitric oxide synthase inhibition reduces caudate injury following transient focal ischemia in cats.
Nishikawa T; Kirsch JR; Koehler RC; Miyabe M; Traystman RJ
Stroke; 1994 Apr; 25(4):877-85. PubMed ID: 7512764
[TBL] [Abstract][Full Text] [Related]
8. Time dependence of effect of nitric oxide synthase inhibition on cerebral ischemic damage.
Zhang F; Xu S; Iadecola C
J Cereb Blood Flow Metab; 1995 Jul; 15(4):595-601. PubMed ID: 7540621
[TBL] [Abstract][Full Text] [Related]
9. NG-Nitro-L-arginine protects against ischaemia-induced increases in nitric oxide and hippocampal neuro-degeneration in the gerbil.
Caldwell M; O'Neill M; Earley B; Leonard B
Eur J Pharmacol; 1994 Aug; 260(2-3):191-200. PubMed ID: 7527344
[TBL] [Abstract][Full Text] [Related]
10. Anti-ischaemic efficacy of a nitric oxide synthase inhibitor and a N-methyl-D-aspartate receptor antagonist in models of transient and permanent focal cerebral ischaemia.
Dawson DA; Graham DI; McCulloch J; Macrae IM
Br J Pharmacol; 1994 Sep; 113(1):247-53. PubMed ID: 7529111
[TBL] [Abstract][Full Text] [Related]
11. A narrow therapeutical window of a nitric oxide synthase inhibitor against transient ischemic brain injury.
Nagafuji T; Sugiyama M; Matsui T; Koide T
Eur J Pharmacol; 1993 Dec; 248(4):325-8. PubMed ID: 7514138
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms involved in the neuroprotective activity of a nitric oxide synthase inhibitor during focal cerebral ischemia.
Buisson A; Margaill I; Callebert J; Plotkine M; Boulu RG
J Neurochem; 1993 Aug; 61(2):690-6. PubMed ID: 7687658
[TBL] [Abstract][Full Text] [Related]
13. Effect of nitric oxide synthase inhibition on cerebral blood flow and injury volume during focal ischemia in cats.
Nishikawa T; Kirsch JR; Koehler RC; Bredt DS; Snyder SH; Traystman RJ
Stroke; 1993 Nov; 24(11):1717-24. PubMed ID: 7694394
[TBL] [Abstract][Full Text] [Related]
14. Nitro-L-arginine analogues. Dose- and time-related nitric oxide synthase inhibition in brain.
Traystman RJ; Moore LE; Helfaer MA; Davis S; Banasiak K; Williams M; Hurn PD
Stroke; 1995 May; 26(5):864-9. PubMed ID: 7537926
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of interleukin-1-alpha-induced nitric oxide synthase in vascular smooth muscle and full reversal of interleukin-1-alpha-induced hypotension by N omega-amino-L-arginine.
Kilbourn RG; Gross SS; Lodato RF; Adams J; Levi R; Miller LL; Lachman LB; Griffith OW
J Natl Cancer Inst; 1992 Jul; 84(13):1008-16. PubMed ID: 1376778
[TBL] [Abstract][Full Text] [Related]
16. Nitric oxide synthase inhibition by L-NAME prevents brain acidosis during focal cerebral ischemia in rabbits.
Regli L; Held MC; Anderson RE; Meyer FB
J Cereb Blood Flow Metab; 1996 Sep; 16(5):988-95. PubMed ID: 8784244
[TBL] [Abstract][Full Text] [Related]
17. Anti-nociceptive activity of nitric oxide synthase inhibitors in the mouse: dissociation between the effect of L-NAME and L-NMMA.
Babbedge RC; Hart SL; Moore PK
J Pharm Pharmacol; 1993 Jan; 45(1):77-9. PubMed ID: 7679442
[TBL] [Abstract][Full Text] [Related]
18. Determination of brain nitric oxide synthase inhibition in vivo: ex vivo assays of nitric oxide synthase can give incorrect results.
Salter M; Duffy C; Hazelwood R
Neuropharmacology; 1995 Mar; 34(3):327-34. PubMed ID: 7543191
[TBL] [Abstract][Full Text] [Related]
19. The neuroprotective effect of a nitric oxide inhibitor in a rat model of focal cerebral ischaemia.
Buisson A; Plotkine M; Boulu RG
Br J Pharmacol; 1992 Aug; 106(4):766-7. PubMed ID: 1382786
[TBL] [Abstract][Full Text] [Related]
20. Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase.
Huang Z; Huang PL; Panahian N; Dalkara T; Fishman MC; Moskowitz MA
Science; 1994 Sep; 265(5180):1883-5. PubMed ID: 7522345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
